MétaCan
Menu
Back to cohort

PO-016 Inhibition of cell proliferation by anti-epidermal growth factor receptor (EGFR) aptamer conjugated chitosan/siRNA nanoparticles

2018· article· en· W2809970955 on OpenAlexaffabout
Qin Shi, Maicon Segalla Petrônio, Elsa-Patricia Rondon-Cavanzo, M.J. Tiera, Mouna Ferdebouh, Mohamed Benderdour, Julio Fernandes

Bibliographic record

VenueESMO Open · 2018
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicRNA Interference and Gene Delivery
Canadian institutionsUniversité de MontréalHôpital du Sacré-Cœur de Montréal
Fundersnot available
KeywordsEpidermal growth factor receptorAptamerChitosanEpidermal growth factorChemistryConjugated systemCell biologyCell growthCancer researchBiophysicsReceptorMolecular biologyBiologyBiochemistry

Abstract

fetched live from OpenAlex

Introduction Gene silencing mediated by small interfering RNA (siRNA) has been widely investigated as a potential therapeutic approach. Its use, however, is hampered by its rapid degradation and poor cellular uptake into cells. Therefore, the success will depend on the design of effective systems able to selectively and efficiently deliver siRNA to target cells/organs. Our strategy relies on the use of a biocompatible biopolymer (chitosan) as carrier of siRNA coupled with specific anti-EGFR aptamers for cell targeting which is overexpressed in various cancer cells. Finally, poly (ethylene glycol) (PEG) and diethylaminoethyl (DEAE) will be covalently-linked with chitosan, in order to improve blood residency and transfection efficiency. The selected siRNA will be directed to silence receptor activator of nuclear factor-kB ligand (RANKL). Its levels are elevated in numerous cancers. Blockage of EGFR by aptamer and knockdown of RANKL by siRNA inhibit cancer cell proliferation in vitro. Material and methods Synthesise and characterise chitosan conjugates: poly (ethylene glycol) (PEG), diethylaminoethyl (DEAE), and anti-EGFR-aptamer are covalently-linked with chitosan. Synthetize, purify and characterise DEAE/PEG/anti-EGFR-aptamer-chitosan/siRNA nanoparticles Optimise the nanoformulations (adjusting polymeric and charge ratios) through tests in vitro including transfection efficacy and cell proliferation assays in different cancer cell lines. Results and discussions Nanoparticles were produced on the basis of our previous results. Particle size and zeta potential were measured by Zetasizer Nano ZS90 (Malvern Instruments Ltd., Malvern, UK). The sizes of synthesised nanoparticles were around 259±3 nm for Chitosan-DEAE15/siRNA with a zeta potential of +28.3±0.8 mV. The average cell viability of free siRNA or nanoparticle-treated cells was 89%–97% compared to nonrelated cells. The results showed that anti-EGFR-aptamer-chitosan/siRNA nanoparticles had a dose-dependent inhibition of cell proliferation. These nanoparticles had a significant inhibition effect of RANKL mRNA expression (RT-PCR assay. Conclusion Conventional cancer treatments such as chemotherapy have severe side toxicity on both tumour and host cells. Biological targeted agents such as monoclonal antibodies are available, but costly. EGFR and RANKL are two of major targets for drug development for cancer treatment. Non-viral gene therapy involved aptamer-EGFR and siRNA-RANKL is a promising therapy strategy. The supportIng grant was from MESI-Quebec (PSR-SIIRI, 2017–2020).

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.015
Threshold uncertainty score0.553

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.014
GPT teacher head0.254
Teacher spread0.240 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueESMO OpenSame topicRNA Interference and Gene DeliveryFrench-language works237,207